CA2460653A1 - Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant - Google Patents

Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant Download PDF

Info

Publication number
CA2460653A1
CA2460653A1 CA002460653A CA2460653A CA2460653A1 CA 2460653 A1 CA2460653 A1 CA 2460653A1 CA 002460653 A CA002460653 A CA 002460653A CA 2460653 A CA2460653 A CA 2460653A CA 2460653 A1 CA2460653 A1 CA 2460653A1
Authority
CA
Canada
Prior art keywords
novx
polypeptide
nucleic acid
protein
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002460653A
Other languages
English (en)
Inventor
John P. Ii Alsobrook
Enrique Alvarez
David W. Anderson
Melanie Baron
Ferenc L. Boldog
Catherine E. Burgess
Stacie J. Casman
Andrei Chapoval
Mohanraj Dhanabal
Shlomit R. Edinger
Andrew Eisen
Karen Ellerman
Seth Ettenberg
Esha A. Gangolli
Valerie L. Gerlach
Linda Gorman
William M. Grosse
Xiaojia Guo
Craig Hackett
Weizhen Ji
Ramesh Kekuda
Nikolai V. Khramtsov
Denise M. Lepley
Li Li
John R. Macdougall
Uriel M. Malyankar
Ann Mazur
Kelly Mcqueeney
Peter S. Mezes
Charles E. Miller
Isabelle Millet
Vishnu S. Mishra
Muralidhara Padigaru
Meera Patturajan
Carol E. A. Pena
John A. Peyman
Luca Rastelli
Daniel K. Rieger
Suresh G. Shenoy
Richard A. Shimkets
Glennda Smithson
Gary Starling
Kimberley A. Spytek
David J. Stone
Velizar T. Tchernev
Nancy Twomlow
Corine A. M. Vernet
Bryan D. Zerhusen
Mei Zhong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CuraGen Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from US10/287,971 external-priority patent/US20040067882A1/en
Publication of CA2460653A1 publication Critical patent/CA2460653A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention se rapporte à de nouveaux polypeptides, et aux acides nucléiques les codant, présentant des propriétés de stimulation de réponses biochimiques ou physiologiques dans une cellule, un tissu, un organe ou un organisme. Plus particulièrement, ces nouveaux polypeptides sont des produits géniques de nouveaux gènes, ou des fragments déterminés biologiquement actifs ou des dérivés de ces derniers. L'invention a également trait à des méthodes d'utilisation regroupant des procédés d'analyse diagnostique et pronostique, ainsi qu'à des méthodes de traitement de différentes conditions pathologiques.
CA002460653A 2001-11-05 2002-11-05 Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant Abandoned CA2460653A1 (fr)

Applications Claiming Priority (39)

Application Number Priority Date Filing Date Title
US33862601P 2001-11-05 2001-11-05
US60/338,626 2001-11-05
US33660001P 2001-12-05 2001-12-05
US60/336,600 2001-12-05
US33828501P 2001-12-07 2001-12-07
US60/338,285 2001-12-07
US34134601P 2001-12-12 2001-12-12
US60/341,346 2001-12-12
US34147701P 2001-12-17 2001-12-17
US34154001P 2001-12-17 2001-12-17
US60/341,540 2001-12-17
US60/341,477 2001-12-17
US34259201P 2001-12-20 2001-12-20
US60/342,592 2001-12-20
US34429701P 2001-12-27 2001-12-27
US60/344,297 2001-12-27
US34490301P 2001-12-31 2001-12-31
US60/344,903 2001-12-31
US37328802P 2002-04-17 2002-04-17
US60/373,288 2002-04-17
US38098102P 2002-05-15 2002-05-15
US60/380,981 2002-05-15
US38149502P 2002-05-17 2002-05-17
US60/381,495 2002-05-17
US38353402P 2002-05-28 2002-05-28
US38374402P 2002-05-28 2002-05-28
US60/383,534 2002-05-28
US60/383,744 2002-05-28
US38382902P 2002-05-29 2002-05-29
US38402402P 2002-05-29 2002-05-29
US60/383,829 2002-05-29
US60/384,024 2002-05-29
US40178802P 2002-08-07 2002-08-07
US60/401,788 2002-08-07
US40635302P 2002-08-26 2002-08-26
US60/406,353 2002-08-26
US10/287,971 2002-10-31
PCT/US2002/035536 WO2003040330A2 (fr) 2001-11-05 2002-11-05 Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
US10/287,971 US20040067882A1 (en) 2001-10-22 2002-11-05 Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Publications (1)

Publication Number Publication Date
CA2460653A1 true CA2460653A1 (fr) 2003-05-15

Family

ID=32512865

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002460653A Abandoned CA2460653A1 (fr) 2001-11-05 2002-11-05 Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant

Country Status (3)

Country Link
EP (1) EP1539985A4 (fr)
CA (1) CA2460653A1 (fr)
WO (1) WO2003040330A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20050053988A1 (en) * 2003-08-08 2005-03-10 The Gov. Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Gene expressed in breast cancer and methods of use
WO2005072340A2 (fr) 2004-01-27 2005-08-11 Compugen Ltd. Nouveaux polynucleotides codant pour des polypeptides et leurs procedes d'utilisation
AU2005269758B2 (en) 2004-07-20 2011-11-03 Genentech, Inc. Compositions and methods of using angiopoietin-like 4 protein
SI1771474T1 (sl) 2004-07-20 2010-06-30 Genentech Inc Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
US8604185B2 (en) 2004-07-20 2013-12-10 Genentech, Inc. Inhibitors of angiopoietin-like 4 protein, combinations, and their use
WO2006043271A1 (fr) * 2004-10-22 2006-04-27 Compugen Ltd. Nouvelles sequences d'acides amines et sequences nucleotidiques et methodes d'utilisation de celles-ci pour le diagnostic
US10842849B2 (en) * 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891426B1 (fr) * 1996-03-11 2006-05-31 Bayer Corporation Bikunine humaine

Also Published As

Publication number Publication date
WO2003040330A2 (fr) 2003-05-15
EP1539985A2 (fr) 2005-06-15
EP1539985A4 (fr) 2006-06-28
WO2003040330A8 (fr) 2005-04-21

Similar Documents

Publication Publication Date Title
CA2486490A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
CA2451454A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant, et modalites d'emploi correspondantes
US20030199442A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2455389A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ceux-ci et procedes d'utilisation
US20030219823A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20040014058A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
CA2460653A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
CA2451254A1 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
CA2455225A1 (fr) Nouvelle proteines et acides nucleiques codant celles-ci
CA2465239A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et procedes d'utilisation correspondant
CA2400360A1 (fr) Nouveaux polypeptides et acides nucleiques les codant
CA2463325A1 (fr) Nouvelles proteines et acides nucleiques codant ces proteines
CA2480450A1 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
CA2391885A1 (fr) Nouveaux polypeptides et acides nucleiques codant pour ces polypeptides
US20060234255A1 (en) Novel proteins and nucleic acids encoding same
US20040067505A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2470012A1 (fr) Nouvelles proteines et acides nucleiques codant ces dernieres
CA2471480A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
US20040229779A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2442739A1 (fr) Nouveaux anticorps se liant a des polypeptides antigeniques, acides nucleiques codant pour ces antigenes, et procedes d'utilisation de ceux-ci
WO2004089282A2 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et procedes d'utilisation correspondants
CA2485089A1 (fr) Polypeptides therapeutiques, acides nucleiques codant pour lesdits polypeptides et methodes d'utilisation
CA2481039A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation
CA2446427A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et methodes d'utilisation
US20040002453A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
FZDE Discontinued